TI
Telemetry Investments’s Gain Therapeutics GANX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $385K | Sell |
123,000
-27,000
| -18% | -$84.5K | 0.61% | 41 |
|
|
2022
Q3 | $489K | Sell |
150,000
-10,000
| -6% | -$32.6K | 0.63% | 46 |
|
|
2022
Q2 | $576K | Sell |
160,000
-80,000
| -33% | -$288K | 0.68% | 42 |
|
|
2022
Q1 | $979K | Buy |
240,000
+88,868
| +59% | +$363K | 1.55% | 14 |
|
|
2021
Q4 | $807K | Buy |
151,132
+54,900
| +57% | +$293K | 1.04% | 22 |
|
|
2021
Q3 | $716K | Buy |
96,232
+65,939
| +218% | +$491K | 0.96% | 37 |
|
|
2021
Q2 | $303K | Buy |
+30,293
| New | +$303K | 0.42% | 75 |
|